Journals / Ege Tıp Dergisi / 2019 / Cilt: 58 - Sayı: 3

Demographic and clinical characteristics of cerebral palsy patients

Serebral palsili hastaların demografik ve klinik özellikleri

Pages
265–273
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Knowing the epidemiologic character of cerebral palsy, regular follow-up, treatment of the patients can provide the least dependence on the child, increase the adaptation to the gathering.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The objective of this study is to identify the demographic and clinical characteristics of our patients who were followed up and treated with cerebral palsy diagnosis.
📊
Key Findings & Data:Materials and Methods: The information of 577 patients was analyzed.
💡
Conclusion & Impact:Conclusion: Knowing the epidemiologic character of cerebral palsy, regular follow-up, treatment of the patients can provide the least dependence on the child, increase the adaptation to the gathering.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: The objective of this study is to identify the demographic and clinical characteristics of our patients who were followed up and treated with cerebral palsy diagnosis. Materials and Methods: The information of 577 patients was analyzed. Results: 41.9% of patients were female,58.1% were male, the mean age was 6.57years. Age of diagnosis was 31.4% in 0-6 months; 36.7% at 6-12 months; 21.9% at 1-2 years and 10.1% after two years of age. There was spastic unilateral type in 23.2%, spastic bilateral type in 72.4%, dyskinetic type in 1.2%, hypotonic type in 0.2% and mixed type in 2.9% of the cases. In terms of etiologic factors,5% prenatal,10.6% perinatal,6.8% postnatal factors were affected.64% of our patients had more than one risk factor, 13.7% had no risk factor. The duration of resumption to the rehabilitation center is 3.05 years. In 51% of the patients there was a concomitant problem, in 49% there was no accompanying problem. Antispastic therapy was used in 9,6% of patients, anticonvulsant therapy in 22,6%, both treatment in 3,1%, others medical treatment in 8,4%. In 56,3% of the patients was no medical treatment.33,1% of patients were using orthosis,23,3% were using assistive devices. According to CMFCS,18.5% of the patients were in stage 1,25.5% in stage 2,18.4% in stage 3, 22.7% in stage 4 and 14.9% in stage 5. Pes equinus was detected most frequently. Botulinum toxin injection was applied in 42,3%, selective dorsal rhizotomy in 0,7% and orthopedic surgery in 21% of our patients. Conclusion: Knowing the epidemiologic character of cerebral palsy, regular follow-up, treatment of the patients can provide the least dependence on the child, increase the adaptation to the gathering.

Özet

Amaç: Çalışmamızın amacı serebral palsi (SP) polikliniğinde SP tanısı ile takip ve tedavisi yapılan hastalarımızın demografik ve klinik özelliklerini belirlemektir. Gereç ve Yöntem: Düzenli takibi olan 577 hastanın bilgileri geriye dönük incelendi. Hastaların yaşı, cinsiyeti, etiyolojik faktörleri, problemlerin fark edildiği yaş, SP tipi, kaba motor fonksiyon klasifikasyon sistemiyle (KMFKS) değerlendirmesi, eşlik eden ikincil problemleri, muayene bulguları, rehabilitasyon merkezinde düzenli tedavi hizmeti alımı, ortez ve yardımcı cihazları, medikal tedavileri, uygulanan konservatif ve cerrahi tedavi yaklaşımları kaydedildi. Bulgular: Hastalarımızın %41,9’u kız, %58,1’i erkek, yaş ortalaması 6,57 (±3,17) yıl idi. Tanı alma yaşı 0-6 ayda %31,4; 6-12 ayda %36,7; 1-2 yaşta %21,9 ve iki yaşından sonra %10,1 idi. Olguların %23,2’sinde spastik unilateral tip, %72,4’ünde spastik bilateral tip, %1,2’sinde diskinetik tip, %0,2’sinde hipotonik tip ve %2,9’unda mikst tip tutulum mevcuttu. Etiyolojik faktörler açısından %5 prenatal, %10,6 perinatal, %6,8 postnatal faktörler etkendi. Hastalarımızın %64’ünde birden çok risk faktörü mevcutken, %13,7’sinde risk faktörü saptanmamıştır. Rehabilitasyon merkezine devam süresi 3,05(±2,8) yıldı. Hastaların %51'inde eşlik eden problem mevcutken %49’unda eşlik eden problem yoktu. Hastalarımızın %9,6’sında antispastik tedavi, %22,6‘sında antikonvülzan tedavi, %3,1’inde antispastik ve antikonvülzan tedavi, %8,4’ünde bunların dışında medikal tedavi mevcutken, %56,3’ünde herhangi bir medikal tedavisi yoktu. Hastaların ilk başvuruda %33,1’i ortez, %23,3'ü yardımcı cihaz kullanmaktaydı. KMFKS’ye göre hastaların %18,5’i evre 1, %25,5’i evre 2, %18,4’ü evre 3, %22,7’si evre 4 ve %14,9’u evre 5 idi. En sık ekin yürüyüşü saptandı. Hastalarımızın %42,3’üne botulinum toksin enjeksiyonu, %0,7’sine selektif dorsal rizotomi, %21’ine ortopedik cerrahi uygulanmıştı. Sonuç: Serebral palsinin epidemiyolojik karakterinin bilinmesi, hastaların düzenli takibi ve tedavisi çocuğun bağımlılığını en aza indirip topluma uyumunun artmasını sağlayabilir.

🔖

Cite This Article

SULTANOĞLU, T., AKYÜZ, E. Ü., ÇEVİKOL, A., SULTANOĞLU, H. (2019). Demographic and clinical characteristics of cerebral palsy patients. Ege Tıp Dergisi, Cilt: 58 - Sayı: 3, 265–273. https://ajindex.com/articles/223416

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Rosenbaum P, Paneth N, Leviton A, et al. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl 2007; 109: 8-14
  2. Sankar C, Mundkur N. Cerebral palsy, definition, classification, etiology and early diagnosis. Indian J Pediatr 2005; 72: 865-868
  3. Dormans J, Susman M, Ozaras N and Yalcin S. Serebral Palsi Tedavi ve Rehabilitasyon
  4. Baskı. İstanbul:Mas Matbaacilik; 2000: 13-93
  5. Matthews DJ, Wilson P. Cerebral Palsy. In:Molnar G.E, Alexander MA (ed). Pediatric Rehabilitation, 3nd ed. Philadelphia: Hanley and Belfus Inc; 1999: 193-219
  6. Serdaroğlu A, Cansu A, Özkan S and Tezcan S. Prevalance of Cerebral Palsy in Turkish Children between the Ages of 2 and 16 Years. Developmental Medicine Child Neurology 2006; 48: 413-416
  7. Dursun N. Serebral Palsi. In: Oğuz H, Dursun E, Dursun, editors. Tıbbi Rehabilitasyon. 1st ed. İstanbul: Nobel Tıp Kitapevleri; 2004: 957-74
  8. Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth Scale of muscle spasticity. Phys Ther 1987; 67 (2): 206-207
  9. Ansari NN, Naghdi S, Younesian P. Interand intrarater reliability of the Modified Modified Ashworth Scale in patients with knee extensor poststroke spasticity. Physiother Theory Pract 2008; 24 (3): 205-213
  10. Boyd RN, Graham HK. Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with traumatic brain injury, cerebral palsy and typically developing children. Dev Neurorehabil 2009; 12: 100-105
  11. Donker SF, Ledebt A, Roerdink M. Children with cerebral palsy exhibit greater and more regular postural sway than typically developing children. Exp Brain Res 2008; 184: 363-370
  12. Liao SF, Yang TF, Hsu TC. Differences in seated postural kontrol in children who are typically developing. Am J Phys Med Rehabil 2003; 82: 622-626
  13. Hagberg B, Hagberg G and Olow I. The Changing Panaroma of Cerebralpalsy in Sweden. I. Prevelance and Origin during the Birth Year Period 1983-1986. Acta Paediatrica 1993; 82: 387-393
  14. Russell DJ, Rosenbaum PL, Cadman DT. The gross motor function measure: a means to evaluate the effects of physical therapy. Dev Med Child Neurol 1989; 31: 341-352
  15. Tütüncüoğlu S, Erermiş S, Aydın M, Özkııl Y, Erciyes H. Serebral Felçli Olguların Değerlendirilmesi. Klinik Bilimler Pediatride Yönelişler 1995; 3: 28-32
  16. Laisram N, Srivastava VK, Srivastava RK. Cerebral palsy-an etiological study. Indian J Pediatr 1992; 59 (6): 723-728